Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) insider Carlos Nueno sold 29,432 shares of the stock in a transaction that occurred on Friday, November 6th. The stock was sold at an average price of $9.20, for a total value of $270,774.40. Following the completion of the transaction, the insider owned 35,312 shares in the company, valued at approximately $324,870.40. The trade was a 45.46% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Teladoc Health Stock Performance
Shares of Teladoc Health stock opened at $9.01 on Tuesday. The stock has a market capitalization of $1.64 billion, a PE ratio of -10.47 and a beta of 2.00. Teladoc Health, Inc. has a 52 week low of $4.40 and a 52 week high of $9.89. The stock has a 50 day moving average price of $6.56 and a two-hundred day moving average price of $6.55.
Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Wednesday, October 28th. The health services provider reported ($0.15) earnings per share for the quarter, topping analysts' consensus estimates of ($0.22) by $0.07. Teladoc Health had a negative return on equity of 11.63% and a negative net margin of 6.27%. The company had revenue of $605.10 million for the quarter, compared to analyst estimates of $588.14 million. During the same period in the prior year, the firm earned ($0.28) earnings per share. Teladoc Health's revenue for the quarter was down 3.4% on a year-over-year basis. Research analysts forecast that Teladoc Health, Inc. will post -0.86 EPS for the current year.
Institutional Trading of Teladoc Health
Several institutional investors and hedge funds have recently made changes to their positions in TDOC. Renaissance Technologies LLC raised its holdings in shares of Teladoc Health by 1.3% in the first quarter. Renaissance Technologies LLC now owns 8,085,542 shares of the health services provider's stock valued at $44,066,000 after purchasing an additional 107,400 shares during the last quarter. Monaco Asset Management SAM purchased a new position in Teladoc Health during the second quarter worth about $26,864,000. Pale Fire Capital SE boosted its holdings in Teladoc Health by 74.8% during the first quarter. Pale Fire Capital SE now owns 3,398,491 shares of the health services provider's stock worth $18,522,000 after purchasing an additional 1,454,288 shares during the last quarter. Quantinno Capital Management LP grew its position in Teladoc Health by 128.0% in the 1st quarter. Quantinno Capital Management LP now owns 2,621,378 shares of the health services provider's stock worth $14,287,000 after purchasing an additional 1,471,631 shares in the last quarter. Finally, Counterpoint Mutual Funds LLC grew its position in Teladoc Health by 1,017.4% in the 3rd quarter. Counterpoint Mutual Funds LLC now owns 1,650,165 shares of the health services provider's stock worth $9,571,000 after purchasing an additional 1,502,488 shares in the last quarter. Hedge funds and other institutional investors own 76.82% of the company's stock.
Analyst Ratings Changes
A number of analysts have commented on TDOC shares. JPMorgan Chase & Co. boosted their price target on shares of Teladoc Health from $8.00 to $10.00 and gave the company a "neutral" rating in a research note on Friday, October 30th. Citigroup dropped their price objective on shares of Teladoc Health from $11.00 to $7.50 and set a "neutral" rating on the stock in a research note on Monday, August 3rd. Bank of America lifted their price objective on shares of Teladoc Health from $10.50 to $11.50 in a report on Thursday, October 29th. Stifel Nicolaus boosted their target price on shares of Teladoc Health from $5.50 to $6.50 and gave the stock a "hold" rating in a research report on Thursday, October 29th. Finally, Oppenheimer boosted their target price on shares of Teladoc Health from $7.00 to $10.00 and gave the stock an "outperform" rating in a research report on Monday, November 2nd. Five equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $8.53.
Read Our Latest Stock Report on TDOC
Teladoc Health Company Profile
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services and technology designed to connect patients with medical professionals remotely. Through its digital platforms, the company supports a range of healthcare needs, including general medical consultations, mental health services, specialty care, and ongoing management of chronic conditions.
Its offerings include telehealth visits with physicians and other licensed providers, behavioral health services through BetterHelp, and chronic care programs that use digital tools and clinical support to help people manage conditions such as diabetes and hypertension.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
